Arun Timmaraju, currently working at Interpace Biosciences, has extensive experience in bioinformatics, assay development, and data analysis. Arun has contributed significantly to the development and validation of various diagnostic tests, as well as the commercialization of products such as the ThyraMIRv2® miRNA risk classifier. Arun's background in cellular and molecular biology, bioinformatics, and chemistry has equipped him with the skills to excel in their roles across different research and educational institutions.
This person is not in any offices